Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Homologous Recombination Deficiency Across Subtypes of Primary Breast Cancer.

Autor: Yndestad, Synnøve, Engebrethsen, Christina, Herencia-Ropero, Andrea, Nikolaienko, Oleksii, Vintermyr, Olav K., Lillestøl, Reidun K., Minsaas, Laura, Leirvaag, Beryl, Iversen, Gjertrud T., Gilje, Bjørnar, Blix, Egil S., Espelid, Helge, Lundgren, Steinar, Geisler, Jürgen, Aase, Hildegunn S., Aas, Turid, Gudlaugsson, Einar G., Llop-Guevara, Alba, Serra, Violeta, Janssen, Emiel A.M.

Publikováno v: JCO Precision Oncology; 11/1/2023, Vol. 7, p1-10, 10p

Olaparib monotherapy as primary treatment in unselected triple negative breast cancer

Autor: Eikesdal, Hans Petter, Yndestad, Synnøve, Elzawahry, Asmaa, Llop-Guevara, Alba, Gilje, Bjørnar, Blix, Egil Støre, Espelid, Helge, Lundgren, Steinar, Geisler, Jürgen, Vagstad, Geirfinn, Venizelos, Andreas, Minsaas, Laura, Leirvaag, Beryl, Gudlaugsson, Einar, Vintermyr, Olav Karsten, Aase, Hildegunn Siv, Aas, Turid, Balmaña, Judith, Serra, Violeta, Janssen, Emiel, Knappskog, Stian, Lønning, Per Eystein

Publikováno v: Eikesdal, Yndestad, Elzawahry, Llop-Guevara, Gilje, Blix, Espelid, Lundgren, Geisler, Vagstad, Venizelos, Minsaas, Leirvaag, Gudlaugsson, Vintermyr, Aase, Aas, Balmaña, Serra, Janssen, Knappskog, Lønning. Olaparib monotherapy as primary treatment in unselected triple negative breast cancer. Annals of Oncology. 2020:1-10

Externí odkaz: https://hdl.handle.net/10037/20445

BRCA1/2testing in newly diagnosed breast and ovarian cancer patients without prior genetic counselling: the DNA-BONus study

Autor: Høberg-Vetti, Hildegunn, Bjorvatn, Cathrine, Fiane, Bent E, Aas, Turid, Woie, Kathrine, Espelid, Helge, Rusken, Tone, Eikesdal, Hans Petter, Listøl, Wenche, Haavind, Marianne T, Knappskog, Per M, Haukanes, Bjørn Ivar, Steen, Vidar M, Hoogerbrugge, Nicoline

Publikováno v: European Journal of Human Genetics: EJHG; June 2016, Vol. 24 Issue: 6 p881-888, 8p